csirt@kutim:~/threat-intel/cve/CVE-2024-35905

Katalog CVE

CVSS 7.8 · High EPSS 0,22%

Kerentanan Improper Validation of Array Index pada linux kernel, debian linux. Skor CVSS 3.1 7.8 (High) menurut NVD.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: bpf: Protect against int overflow for stack access size This patch re-introduces protection against the size of access to stack memory being negative; the access size can appear negative as a result of overflowing its signed int representation. This should not actually happen, as there are other protections along the way, but we should protect against it anyway. One code path was missing such protections (fixed in the previous patch in the series), causing out-of-bounds array accesses in check_stack_range_initialized(). This patch causes the verification of a program with such a non-sensical access size to fail. This check used to exist in a more indirect way, but was inadvertendly removed in a833a17aeac7.

Rincian

Terbit di NVD
19 Mei 2024
Terakhir diubah
4 Agustus 2026
Status NVD
Modified
CVSS 3.1
7.8 (High), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-129: Improper Validation of Array Index
CWE-190: Integer Overflow or Wraparound
EPSS (30 hari)
0,22% peluang dieksploitasi; lebih tinggi dari 12,2% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
linux linux kernel Versi 5.10.209 hingga sebelum 5.10.215
linux linux kernel Versi 5.15.148 hingga sebelum 5.15.154
linux linux kernel Versi 6.1.75 hingga sebelum 6.1.85
linux linux kernel Versi 6.6.14 hingga sebelum 6.6.26
linux linux kernel Versi 6.7.2 hingga sebelum 6.8.5
linux linux kernel Versi 6.9 rc1
debian debian linux Versi 10.0

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.